name | 王小萍 |
sex | female
|
age | 42 岁 |
hospital number | 900454 |
height | 158 cm |
weight | 55 kg |
BSA | 1.64 m2 |
APACHEⅡ | 20 分 |
Infection source | lung
|
date | 2017/10/29 年/月/日 |
Sequential Organ Failure Assessment | 16 分 |
Fluid resuscitation | CVP8-12 mmHg
/MAP≥65 mmHg
/ScvO2≥70%
/urine volume≥0.5
|
age>=60 | no
|
septic shock | yes
|
mechanical ventilation | trachea cannula
|
Early fluid resuscitation | yes
|
age<60 | yes
|
Pregnant woman | no
|
advanced malignant tumor | no
|
Pulmonary interstitial fibrosis | no
|
Serious arrhythmia | no
|
Small Tidal Volume Ventilation | no
|
Liver failure | no
|
Refuse to participate | no
|
Heart disease | no
|
no
|
|
no
|
|
no
|
|
no
|
|
no
|
- vital signs
- Blood Gas Analysis
- vasoactive agent and fluid
- PiCCO parameters
- Cardiac Ultrasound
- lung ultrasound
- inferior vena cava
yes
|
|
泰能 1.0 ivgtt q8h |
|
vasoactive agent | norepinephrine
|
100 min |
|
60 min |
|
30 min |
Temperature | 37.2 ℃ |
Heart Rate | 134 次/分 |
Breath | 22 次/分 |
Systolic pressure (SP) | 150 mmHg |
Diastolic pressure | 84 mmHg |
mean arterial pressure | 109 mmHg |
Pcv-aCO2 | -4.7 mmHg |
DO2 | 687.2 |
VO2 | 137.5 |
Ca-vO2 | 26.3 |
pH value | 7.42 |
PaO2 | 56.4 mmHg |
PaCO2 | 25.8 mmHg |
BE | -7 mmol/L(±2.3mmol/L) |
SaO2 | 87.6 % |
Blood lactic acid concentration, LAC | 1.6 mmol/L |
Oxygenation index (PaO2/FiO2) | 80.6 mmHg |
pH value | 7.38 |
PcvO2 | 32.1 mmHg |
PcvCO2 | 21.1 mmHg |
BE | -8 mmol/L |
ScvO2 | 70.1 % |
Volume of input | 0 ml |
Volume of output | 0 ml |
Volume of urine | 0 ml |
ultrafiltration volume | 0 ml |
norepinephrine | yes
|
Norepinephrine Dosage | 2.2 μg/Kg/min |
dopamine | no
|
Dopamine Dosage | 0 μg/Kg/min |
Dobutamine | No
|
Dobutamine Dosage | 0 μg/Kg/min |
CVP | 17 mmHg |
cardiac output | 5.22 L/min |
cardiac index | 5.18 L/min/m2 |
stroke volume | 39 ml |
Stroke Index | 25.8 ml/m2 |
ITBVI | 1461 ml/m2 |
GEDVI | 1169 ml/m2 |
EVLWI | 9.8 ml/kg |
PVPI | 2.5 |
SVRI | 2311 DSm2/cm5 |
CFI | 4 |
GEF | 14 % |
SVV | 3 % |
PPV | % |
dPmax | 1683 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
the number of B line | 5 条 |
LUS | 6 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 18 mm |
IVC(expiratory phase) | 16 mm |
respiratory variations of inferior vena cavae diameter | 11 % |
13 mm |
|
10 mm |
|
10 mm |
|
8 mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 36.9 ℃ |
Heart Rate | 100 次/分 |
Breath | 18 次/分 |
Systolic Pressure | 124 mmHg |
Diastolic Pressure | 85 mmHg |
Mean Arterial Pressure | 100 mmHg |
Pcv-aCO2 | -8.6 mmHg |
DO2 | 621.7 |
VO2 | 176.5 |
Ca-vO2 | 41.5 |
PH value | 7.32 |
PaO2 | 122 mmHg |
PaCO2 | 28.6 mmHg |
BE | 10.8 mmol/L |
SaO2 | 99 % |
Blood Lactic Acid Concentration | 0.8 mmol/L |
Oxygenation index (PaO2/FiO2) | 174.3 mmHg |
PH value | 7.31 |
PcvO2 | 35 mmHg |
PcvCO2 | 20 mmHg |
BE | -11.2 mmol/L |
ScvO2 | 71 % |
Volume of input | 3560 ml |
Volume of output | 2100 ml |
Volume of urine | 2050 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 15 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan |
CVP | 13 mmHg |
cardiac output | 4.25 L/min |
cardiac index | 2.59 L/min/m2 |
stroke volume | 42.5 ml |
Stroke Index | 25.9 ml/m2 |
ITBVI | 707 ml/m2 |
GEDVI | 565 ml/m2 |
EVLWI | 9.4 ml/kg |
PVPI | 2.4 |
SVRI | 2684 DSm2/cm5 |
CFI | 5 |
GEF | 19 % |
SVV | 12 % |
PPV | % |
dPmax | 1683 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 10 条 |
LUS | 8 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 19 mm |
IVC(expiratory phase) | 17 mm |
Respiratory variations of inferior vena cavae diameter | 11 % |
15 mm |
|
10 mm |
|
13 mm |
|
10 mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 37 ℃ |
Heart Rate | 96 次/分 |
Breath | 16 次/分 |
Systolic Pressure | 122 mmHg |
Diastolic Pressure | 74 mmHg |
Mean Arterial Pressure | 92 mmHg |
Pcv-aCO2 | 5.8 mmHg |
DO2 | 952.5 |
VO2 | 224.8 |
Ca-vO2 | 35.8 |
PH value | 7.31 |
PaO2 | 114 mmHg |
PaCO2 | 33.3 mmHg |
BE | -8.6 mmol/L |
SaO2 | 98.2 % |
Blood Lactic Acid Concentration | 0.8 mmol/L |
Oxygenation index (PaO2/FiO2) | 285 mmHg |
PH value | 7.33 |
PcvO2 | 46.5 mmHg |
PcvCO2 | 39.1 mmHg |
BE | -5 mmol/L |
ScvO2 | 75.1 % |
Volume of input | 4800 ml |
Volume of output | 2850 ml |
Volume of urine | 2700 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 25 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan |
CVP | 9 mmHg |
cardiac output | 6.28 L/min |
cardiac index | 3.83 L/min/m2 |
stroke volume | 65.4 ml |
Stroke Index | 39.9 ml/m2 |
ITBVI | 827 ml/m2 |
GEDVI | 662 ml/m2 |
EVLWI | 8.2 ml/kg |
PVPI | 1.8 |
SVRI | 1253 DSm2/cm5 |
CFI | 6 |
GEF | 24 % |
SVV | 3 % |
PPV | % |
dPmax | 596 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 6 条 |
LUS | 5 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 18 mm |
IVC(expiratory phase) | 15 mm |
Respiratory variations of inferior vena cavae diameter | 17 % |
16 mm |
|
12 mm |
|
15 mm |
|
10 mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 36.7 ℃ |
Heart Rate | 94 次/分 |
Breath | 19 次/分 |
Systolic Pressure | 115 mmHg |
Diastolic Pressure | 78 mmHg |
Mean Arterial Pressure | 92 mmHg |
Pcv-aCO2 | -3.3 mmHg |
DO2 | 619.2 |
VO2 | 194.8 |
Ca-vO2 | 40.6 |
PH value | 7.35 |
PaO2 | 103 mmHg |
PaCO2 | 35.3 mmHg |
BE | -5.4 mmol/L |
SaO2 | 98 % |
Blood Lactic Acid Concentration | 0.9 mmol/L |
Oxygenation index (PaO2/FiO2) | 257.5 mmHg |
PH value | 7.31 |
PcvO2 | 60 mmHg |
PcvCO2 | 32 mmHg |
BE | -6 mmol/L |
ScvO2 | 67.2 % |
Volume of input | 5600 ml |
Volume of output | 3100 ml |
Volume of urine | 2860 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 30 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan |
CVP | 7 mmHg |
cardiac output | 4.8 L/min |
cardiac index | 2.93 L/min/m2 |
stroke volume | 51.8 ml |
Stroke Index | 37.1 ml/m2 |
ITBVI | 851 ml/m2 |
GEDVI | 681 ml/m2 |
EVLWI | 10.2 ml/kg |
PVPI | 2.2 |
SVRI | 2122 DSm2/cm5 |
CFI | 4 |
GEF | 19 % |
SVV | 6 % |
PPV | % |
dPmax | 492 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 4 条 |
LUS | 5 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 17 mm |
IVC(expiratory phase) | 13 mm |
Respiratory variations of inferior vena cavae diameter | 24 % |
13 mm |
|
12 mm |
|
12 mm |
|
10 mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 36.8 ℃ |
Heart Rate | 106 次/分 |
Breath | 17 次/分 |
Systolic Pressure | 122 mmHg |
Diastolic Pressure | 83 mmHg |
Mean Arterial Pressure | 97 mmHg |
Pcv-aCO2 | -2.4 mmHg |
DO2 | 602.5 |
VO2 | 164.7 |
Ca-vO2 | 36.0 |
PH value | 7.43 |
PaO2 | 121 mmHg |
PaCO2 | 34.4 mmHg |
BE | -1.1 mmol/L |
SaO2 | 99.1 % |
Blood Lactic Acid Concentration | 1 mmol/L |
Oxygenation index (PaO2/FiO2) | 302.5 mmHg |
PH value | 7.41 |
PcvO2 | 45 mmHg |
PcvCO2 | 32 mmHg |
BE | -2 mmol/L |
ScvO2 | 72.1 % |
Volume of input | 6800 ml |
Volume of output | 4900 ml |
Volume of urine | 4500 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 35 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan |
CVP | 3 mmHg |
cardiac output | 4.57 L/min |
cardiac index | 2.79 L/min/m2 |
stroke volume | 43.1 ml |
Stroke Index | 26.3 ml/m2 |
ITBVI | 921 ml/m2 |
GEDVI | 237 ml/m2 |
EVLWI | 10.9 ml/kg |
PVPI | 2.1 |
SVRI | 2697 DSm2/cm5 |
CFI | 4 |
GEF | 14 % |
SVV | 10 % |
PPV | % |
dPmax | 575 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 6 条 |
LUS | 5 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 18 mm |
IVC(expiratory phase) | 15 mm |
Respiratory variations of inferior vena cavae diameter | 17 % |
16 mm |
|
14 mm |
|
15 mm |
|
12 mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 37.1 ℃ |
Heart Rate | 86 次/分 |
Breath | 18 次/分 |
Systolic Pressure | 129 mmHg |
Diastolic Pressure | 84 mmHg |
Mean Arterial Pressure | 100 mmHg |
Pcv-aCO2 | 0.3 mmHg |
DO2 | 603.7 |
VO2 | 168.2 |
Ca-vO2 | 40.5 |
PH value | 7.55 |
PaO2 | 96.7 mmHg |
PaCO2 | 28.7 mmHg |
BE | 3.1 mmol/L |
SaO2 | 98.5 % |
Blood Lactic Acid Concentration | 1.2 mmol/L |
Oxygenation index (PaO2/FiO2) | 241.8 mmHg |
PH value | 7.52 |
PcvO2 | 46 mmHg |
PcvCO2 | 29 mmHg |
BE | 2.1 mmol/L |
ScvO2 | 71.1 % |
Volume of input | 7200 ml |
Volume of output | 6807 ml |
Volume of urine | 6250 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 35 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan |
CVP | 9 mmHg |
cardiac output | 4.15 L/min |
cardiac index | 2.53 L/min/m2 |
stroke volume | 48.3 ml |
Stroke Index | 29.4 ml/m2 |
ITBVI | 283 ml/m2 |
GEDVI | 626 ml/m2 |
EVLWI | 9.4 ml/kg |
PVPI | 2.2 |
SVRI | 2875 DSm2/cm5 |
CFI | 4 |
GEF | 19 % |
SVV | 5 % |
PPV | % |
dPmax | 549 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 5 条 |
LUS | 3 分 |
B+ Zone | 区 |
IVC(expiratory phase) | 17 mm |
Respiratory variations of inferior vena cavae diameter | 15 % |
IVC(inspiratory phase) | 12 mm |
13 mm |
|
10 mm |
|
12 mm |
|
9 mm |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | 6234 pg/ml |
BNP | pg/ml |
cTNI | 0.025 ng/ml |
Creatine kinase isoenzyme, CKMB | 4 U/L |
Creatinine | 54 umol/L |
Urea nitrogen | 4.4 mmol/l |
MDRD | ml/min/1.73m2 |
Date of examination | yyyy-mm-dd |
WBC | 25.3 X10*9/L |
neutrophilic granulocyte percentage | 96.5 % |
Hb | 112 g/L |
CRP | 288.79 mg/L |
Procalcitonin, PCT | ng/ml |
Date of test |
|
Sequential Organ Failure Assessment | 16 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | 8001 pg/ml |
BNP | pg/ml |
cTNI | 0.277 ng/ml |
Creatine kinase isoenzyme, CKMB | 10 U/L |
Creatinine | 46 umol/L |
Urea nitrogen | 7.4 mmol/l |
MDRD | ml/min/1.73m2 |
WBC | 17 X10*9/L |
neutrophilic granulocyte percentage | 93 % |
Hb | 98 g/L |
CRP | 181.54 mg/L |
Procalcitonin, PCT | 0.048 ng/ml |
Sequential Organ Failure Assessment | 12 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | 15568 pg/ml |
BNP | pg/ml |
cTNI | 0.331 ng/ml |
Creatine kinase isoenzyme, CKMB | 8 U/L |
Creatinine | 52 umol/L |
Urea nitrogen | 12.7 mmol/L |
MDRD | ml/min/1.73m2 |
WBC | 13.7 X10*9/L |
neutrophilic granulocyte percentage | 90 % |
Hb | 98 g/L |
CRP | 132.1 mg/L |
Procalcitonin, PCT | 0.085 ng/ml |
Sequential Organ Failure Assessment | 6 分 |
Transfusion of Red Cells | no
|
Transfusion of Red Cells | U |
Plasma infusion | no
|
Plasma infusion | ml |
platelet transfusion | no
|
platelet transfusion | U |
APACHEⅡ | 12 分 |
Complication | no
|
prognosis | improve
|
28-day mortality | no
|
survival time(day) | 天 |
death time | yyyy/mm/dd |
diagnosis of death |
|
length of stay | 14 天 |
duration in ICU | 5 天 |
duration of mechanical ventilation | 56 小时 |
ICU expenses | 34680 元 |
Continuous Renal Replacement Therapy | no
|
Continuous Renal Replacement Therapy | 小时 |